C. Duru

Emotional and cognitive social processes are impaired in Parkinson's disease and are related to behavioral disorders.

P. Krystkowiak, O. Godefroy, M. Roussel, 2013, Neuropsychology.

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.

Enrico Amico, Philippe Allain, Mark Mühlau, 2017, The Lancet. Neurology.

Association between caffeine intake and age at onset in Huntington's disease

L. Defebvre, A. Destée, L. Buée, 2013, Neurobiology of Disease.

Decrease in blood pressure after intravenous administration of urapidil during recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke.

J. Bugnicourt, O. Godefroy, C. Duru, 2008, Clinical therapeutics.

Hedonic Deficits in Parkinson’s Disease: Is Consummatory Anhedonia Specific?

P. Krystkowiak, O. Godefroy, G. Loas, 2014, Front. Neurol..

A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease

L. Defebvre, L. Buée, A. Dürr, 2009, Neurobiology of Disease.

C08 Caffeine is a modifier of age at onset in Huntington's disease

L. Defebvre, L. Buée, P. Amouyel, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Foam sclerotherapy: a possible cause of ischaemic stroke?

J. Bugnicourt, O. Godefroy, C. Duru, 2010, Journal of Neurology, Neurosurgery & Psychiatry.